Gwang-Cheol Park
Vorstandsvorsitzender bei Premierbio Co., Ltd.
Aktive Positionen von Gwang-Cheol Park
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Premierbio Co., Ltd.
 Premierbio Co., Ltd. Pharmaceuticals: OtherHealth Technology Premierbio Co., Ltd. is engaged in developing Protoxin. It offers development and supply of Botulinum type A Toxin. The company was founded on September 25, 2015 and is headquartered in Anseong, South Korea. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Gwang-Cheol Park
Ehemalige bekannte Positionen von Gwang-Cheol Park
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DSK CO., LTD. | Vorstandsvorsitzender | 30.03.2016 | - |
| Vorsitzender | 30.03.2016 | - | |
| HYUNDAI SECURITIES CO LTD | Direktor/Vorstandsmitglied | 21.06.2010 | - |
| Independent Dir/Board Member | 21.06.2010 | - |
Ausbildung von Gwang-Cheol Park
| Konkuk University | Doctorate Degree |
Statistik
International
| Südkorea | 5 |
Operativ
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sektoral
| Finance | 2 |
| Consumer Services | 2 |
| Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DSK CO., LTD. | Electronic Technology |
| Private Unternehmen | 2 |
|---|---|
KB Securities Co., Ltd
 KB Securities Co., Ltd Investment ManagersFinance KB Securities Co., Ltd (KB Securities) is a private equity subsidiary of KB Financial Group, Inc. founded in 1962. The firm is headquartered in Seoul, South Korea. | Finance |
Premierbio Co., Ltd.
Premierbio Co., Ltd. Pharmaceuticals: OtherHealth Technology Premierbio Co., Ltd. is engaged in developing Protoxin. It offers development and supply of Botulinum type A Toxin. The company was founded on September 25, 2015 and is headquartered in Anseong, South Korea. | Health Technology |
- Börse
- Insiders
- Gwang-Cheol Park
- Erfahrung
